Commentary to Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update
- PMID: 33792849
- PMCID: PMC8014900
- DOI: 10.1007/s40292-021-00446-w
Commentary to Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update
Conflict of interest statement
On behalf of all authors, the corresponding author states that there is no conflict of interest
Comment on
-
Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.High Blood Press Cardiovasc Prev. 2021 Mar;28(2):129-139. doi: 10.1007/s40292-021-00439-9. Epub 2021 Feb 26. High Blood Press Cardiovasc Prev. 2021. PMID: 33635533 Free PMC article. Review.
References
-
- Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, Raizada MK, Grant MB. Oudit GY angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020;126(10):1456–1474. doi: 10.1161/CIRCRESAHA.120.317015. - DOI - PMC - PubMed
-
- Iaccarino G, Borghi C, Cicero AFG, Ferri C, Minuz P, Muiesan ML, Mulatero P, Mulè G, Pucci G, Salvetti M, Savoia C, Sechi LA, Volpe M, Grassi G. Renin-angiotensin system inhibition in cardiovascular patients at the time of COVID19: much ado for nothing? A statement of activity from the directors of the board and the scientific directors of the Italian society of hypertension. High Blood Press Cardiovasc Prev. 2020;27(2):105–108. doi: 10.1007/s40292-020-00380-3. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
